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Abstract.An effort to reduce medication errors is to use drugs prescription electronically. 
However, this system may not be free from errors in medication. This study aimed to find 
out the description of prescribing flow, to examine electronic prescription completeness, 
and find out the potential medication errors that occur in the prescribing phase of electronic 
prescription using prescribing indicators
 
. This study used observational method by 
extracting general practice outpatient prescription data of March 2018 in a healthcare 
service of telecommunication company located in Bandung and analyzed descriptively. The 
electronic prescriptions of medicines at this health care werewritten and inputted by 
physicians. When an error occurred on a computer system, the physician would prescribe 
the required drugs manually so that the patient can still be served. Incompleteness of the 
most common prescription were administrative requirements where all prescriptions did not 
list the physician's license, patient's gender, patient's body weight (BW), telephone number 
of the place of practice, and patient's contact number. Medication errors had the highest 
potency for the occurrence of prescription writing with two or more drugs interacting and 
this error was classified as category D according to The National Coordinating Council for 
Medication Error Reporting and Prevention (NCC-MERP). 
Keyword:Electronic Prescription, Medication Errors, Prescribing Indicators, NCC-MERP 
Abstrak.Upaya untuk mengurangi kesalahan pengobatan adalah dengan menggunakan 
resep obat secara elektronik. Namun, sistim ini belum tentu bebas dari kesalahan dalam 
terapi. Penelitian ini bertujuan untuk mengetahui gambaran alur pelayanan resep obat, 
mengkaji kelengkapan resep elektronik, dan mengetahui potensi kesalahan pengobatan 
yang terjadi pada fase peresepan resep elektronik menggunakan indikator peresepan. 
Penelitian ini menggunakan metode observasional dengan mengambil data resep dokter 
umum pada pasien rawat jalan bulan Maret 2018 di sebuah layanan kesehatan perusahaan 
telekomunikasi yang berlokasi di Bandung dan dianalisis secara deskriptif. Resep obat 
elektronik di layanan kesehatan ini ditulis dan diinput oleh dokter. Ketika kesalahan terjadi 
pada sistim komputer, dokter akan meresepkannya secara manual sehinggga pasien masih 
dapat dilayani.Ketidaklengkapan resep yang paling umum adalah persyaratan administrasi 
di mana semua resep tidak tercantum izin praktik dokter, jenis kelamin pasien, berat badan 
pasien, nomor telepon tempat praktik, dan nomor kontak pasien. Kesalahan pengobatan 
memiliki potensi paling besar untuk terjadinya penulisan resep dengan dua atau lebih obat 
yang berinteraksi dan kesalahan ini diklasifikasikan sebagai kategori D menurut NCC-
MERP. 
Kata Kunci:Resep Elektronik, Kesalahan Pengobatan, Indikator Resep, NCC-MERP 
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1.  Introduction 
Improper prescriptions of drugs can cause errors affecting patients, including clinical outcomes. 
The incidence of medication errors in the world reached 51.8% consisted of administrative, 
pharmacy and clinical aspects[1]. A research in Indonesia showed the potency for medication 
errors in hospitals occurred in many prescribing phases.As much as 74.53% of the prescriptions 
did not include dosage forms and 46.91% were administrative errors and also other significant 
events[2-4]. 
Errors can be caused by unclear communication, environmental conditions, work interruptions, 
work overloads, and poor education. Few efforts can be done to prevent errors in medication. 
One strategy is by improving the system using accurate electronic prescription (e-prescription). 
This system is free from distractions and can be recognized by pharmacist [5-7]. Manual 
prescription writing has been practiced with 6.5 % potential error due to unreadable or unclear 
prescriptions[2]. 
Computerized Physician Order Entry (CPOE) has begun to develop in Indonesia, but there are 
still limited hospitals that use this system. The use of electronic prescriptions does not guarantee 
that medication errors can be avoided. The errors comprise wrong amount of medications, 
wrong direction of measurement, wrong duration of therapy, wrong dose formulation and 
inflexible order format in prescribing ofmost anti-infective, nervous system, inhaler, eye drop 
and topical agents[8]. A study conducted in Indonesia indicated that out of 997 electronic 
prescriptions, 63.8%had incomplete prescriptions. Additionally,26.0% of them had problems 
with potential drug interactions, 6.3% were prescribed with incorrect drugs, 2.1% were multiple 
drug prescriptions, and 1.8%had unusual dosages (1.8%)[9].  
Therefore, this system still needs to be studied to assure safe treatment given to patients. This 
study aimed to find out the description of electronic prescribing flow, to examine e- prescription 
completeness, and analyzed the potential medication errors that occur in the prescribing phase 
of e-prescriptions using prescribing indicators[10-11]. 
2.   Methods 
This retrospective descriptive observational study was carried out byanalyzing the flow of 
electronic prescription services and retrieving data from e-prescription sheets (n=342)consisted 
of 1,383 prescriptions in a health care center Bandung period March-April 2018. The 
assessment results are in the form of electronic drug prescription flow.Assessment of 
administrative completeness was only limited to administrative completeness and 
pharmaceutical suitabilityby referring to the Permenkes RI No. 72 year 2016 concerning 
Standard of Pharmaceutical Services in Hospitals, and potential medication errors by using 
prescribing indicators[9]. The average number of drugs per sheet was further analyzed and 
47 
 
Indonesian Journal of Pharmaceutical and Clinical Research (IDJPCR) Vol. 02, No. 1, 2019 
categorized based on the study that stated that polypharmacy could be categorized as minor (if 
there were 2-3 different drug classes provided to a patient), moderate (if there were 4-5 different 
drug classes provided to patient) and primary (if> 6 different drug classes  provided to patient) 
[12].  
3.   Results and Analysis 
The flow of electronic prescription services can be seen in Figure 1. The flow of the service can 
be described as follow: 
3.1 Registration 
Once the patients arrived at the health care centre, theyimmediately registeredusing the system 
that had been automated. Previously registered patients were required to submit the Personnel 
Registration Number because their data have  already been in the system. Each of these patients 
entered his or her name and the physician‟sname going to seek for treatment. After registration, 
each of these patients received a queue number and waited in the available waiting room. 
3.2 Identification of Patients and Drug Prescribing 
When the patients had registered, the physicians automatically had data of the patientswho 
requested for examination and accessedthe dataas well as the patients‟ medical and medication 
histories on the information system. After the assessment, the physicians wrotethe prescriptions 
by searching the availability of drugs that would be prescribed in the information system, 
printed out the e-prescriptions, and handed inthe prescriptions to the correspondingpatients. It 
was found that sometimes few prescriptions were written manually when errors occurred in the 
system. Thus, the patients could be served. 
 
 
Figure 1. Flow of Electronic Prescription Services 
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3.3 Identification of e-Prescription and Drug Administering to Patients 
The written prescriptions were submitted to the pharmacy for further processing. The pharmacy 
personnel identified the received prescription sheets and checked the availability of the drugs 
required. If drugs were available, the pharmacy personnel would prepare the necessary 
medications according to the prescriptions. The prepared medications wererechecked by the 
pharmacists before being handed into the patients. The  prescribed drugs during the study period 
can be seen in Table 1. The most frequently prescribed drugs were antihypertension, drugs to 
treat dyslipidemia, anticoagulant, antiplatelet, andfibrinolyticdrugs. According to dosage form, 
the most frequently prescribed drugs were tablet/caplet/capsule which reached 98.84%.  
Table 1.Description of the Drugs Prescribed 
Category  Number 
of drug 
items 
Percentage (%)  
Therapeutic Class    
Antihypertension 539  38.97  
Dyslipidemia  155  11.21  
Anticoagulant, Antiplatelet, 
andFibrinolyticdrugs  
113  8.17  
Antidiabetic drugs 109  7.88  
Vitamin and Minerals  103  7.45  
NSAIDs  49  3.54  
Antacids, Antireflux Agent & Antiulcer  49  3.54  
Cough & Cold  35  2.53  
Hyperuricemia and Gout  34  2.46  
Bladder and Prostate Disorders 34  2.46  
Others  163  11.79  
Total  1,383  100  
Dosage form    
Tablet/Caplet/Capsule 1,367  98.84  
Syrup            15  1.09  
Inhaler  1  0.07  
Total  1,383  100  
 
In the pharmacy unit, the pharmacistsonly reviewed2 out of 3 aspects of screening of the 
prescriptions namely administrative completeness and pharmaceutical suitability. The results 
obtained from the study of administrative completeness and pharmaceutical suitability are listed 
in Table 2. 
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Table 2. e-Prescription Completeness and Compatibility Assessment 
Aspects N (%) 
Complete Incomplete Appropriate Inappropriate 
Administrative completeness (n=342)   
Patient‟s name 342 (100) 0(0) - - 
Patient‟s age 341 (99.7) 1 (0.3) - - 
Physician‟s license 0(0) 342(100) - - 
Practice contact number 0(0) 342(100)   
Patient‟sgender 0 (0) 342 (100) - - 
Patient‟s BW 0 (0) 342 (100) - - 
Physician's name 342 (100) 0 (0) - - 
Address of Practice 342 (100) 0(0) - - 
Physician‟s signature 334 (97.7) 8 (2.3) - - 
Additional Formats in Electronic  Prescription  
Prescription Number 334 (97.7) 8 (2.3) - - 
Registration Number 334 (97.7) 8 (2.3) - - 
Special health service 334 (97.7) 8 (2.3) - - 
Type of clinic 334 (97.7) 8 (2.3) - - 
Employment ID number 342 (100) 0(0) - - 
Patient address 139 (40.6) 209 (59.4) - - 
Patient contact number 60 (17.5) 282 (82.5) - - 
Practice contact number 0(0) 342 (100) - - 
Pharmaceuticals (n=1,383)   
Dosage form 1,284 (92.8) 99 (7.2) 1,243 (89.88) 140 (10.12) 
Dose strength 1,247 (90.2) 136 (9.8) 1,378 (99.64) 5 (0.36) 
Number of drugs 1,383 (100) 0 (0) - - 
Usage Instruction 1,383 (100) 0 (0) - - 
 
In the assessment of administrative completeness, the requirement of the prescriptions were 
checked according to Regulation of the Minister of Health of the Republic of Indonesia No. 72 
year 2016 concerning the Standards of Pharmaceutical Services in the Hospital (also referred by 
health clinics), as well as aspects already listed in the electronic prescriptions.  This study found 
that all (100%) of the prescription sheets had nophysician‟s license number and practice contact 
number as well as gender, body weight and contact numbers of the patients. 
In term of pharmaceutical suitability, as much as 9.8% (136 items)of the 1,383 drugs 
analyzeddid not include dose strength, 10.12% (140 items) did not match the existing dosage 
form and 0.36% (5 items) were inappropriate with existing dose strengths. 
In prescribing phase, the indicators that have been studied and used in the assessment were 
overall number of drugs and averagenumber of drug items per prescription sheet, occurrence of 
wrong drug, wrong dose, and error/unclear prescribing, occurrences of prescription writing with 
2 or more potential drug interactions. Drugs prescribed by number of drugs per sheet are shown 
in Table 3. Of the 342 prescriptions extracted, there were 1,383 drugs prescribed.  The average 
number of drug items per prescription was 4.04 rounded to4.  
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Table 3. Drugs prescribed byNumber of Drugs per Sheet 
Number of drugs 
per sheet 
Number of sheets Number of Drug Items  
1  31  31  
2  45  90  
3  70  210  
4  61  244  
5  54  270  
6  43  270  
7  27  189  
8  9  72  
9  1  9  
10  1  10  
Total  342  1,383  
Average Number of Drug Items per  Sheet 4.04  
 
The  number and average  number of drug items  per prescription sheet  were calculated to 
determine the incidence of polypharmacy (the simultaneous use of multiple drugs to treat a 
single ailment or condition). The more the  number of drugswritten in each prescription, the  
higher the  potency of medication errors to occur. This present study found that the average 
number of drug items written in a prescription sheet was 4.04 and categorized into moderate 
polypharmacy. 
Occurrence of wrong drug, wrong dose, and error/unclear prescribing are listed in Table 4. The 
present study was conducted only limited to the inappropriate dosage form (incorrect dosage 
form) and the occurrence of contraindication due to the limited data obtained fromthe electronic 
prescriptions. In the electronic prescriptions the patients‟ clinical conditions were not available. 
The incidence of inappropriate dosage forms was seen from the suitability of the dosage form 
written in the prescription with the available dosage form. For contraindications, it was seen 
from whether there is medication indicated for condition prohibited for the drugs.  
The potential medication errors occurred were categorized into category D in which this 
category stated that „there is an error experienced by the patient and monitoring is needed to 
confirm that it does not cause any harm to the patient and/or intervention needed to prevent the 
harm[13]. This event could occur due to the diseases and symptoms of the disease experienced 
by the patient (complications), so that the prescribers wrote more than one drug to meet the 
needs of these patients. 
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Table 4. Occurrence of Wrong Drug, Wrong Dose, and Error/Unclear Prescribing
[11]
 
Prescribing Indicators N (%) Medication Error 
Category 
Wrong Drug Prescribing   
Inappropriate dosage forms         
Contraindications 
140 (10.12) 
0 (0) 
B 
A 
Total 140 (10.12)  
Wrong Dose   
   Too Low 
   Too High 
103 (7.4) 
12 (0.9) 
D 
D 
Total 115 (8.3)  
Error/Unclear Prescribing   
   Drug name 
   Drug Amount 
   Drug Dose 
5 (0.4) 
46 (3.3) 
5  (0.4) 
B 
B 
B 
Total 56 (4.1)  
 
The results of the analysis showed that there were potential errors in writing dosage forms. This 
potential medication errors can be classified into category B in which an error has occurred but 
the error does not reach the patient, because upon delivery, the drug was given according to the 
available dosage form. In the occurrence of wrong dosage prescribing, the literature states that 
the dose of cetirizine was 5-10 mg per day, but the dose given was 10 mg 3 times a day, so the 
dose given can be categorized as too high. Based on the results of the analysis using the 
algorithm for determining Medication Errors or NCC MERP Index for Categorizing Medication 
Errors, the incidence of too low and too high doses were categorized into category D namely the 
occurrence of errors that reach the patient and monitoring is needed to confirm that it does not 
cause harm to the patient and/or interventions is needed to prevent harm. Provision of too low 
dose can lead to ineffective treatment in which the disease suffered by the patient was not 
properly treated.Too high doses mayresult in toxic effects to the body organs, reduce the 
patients‟ quality of life, and even death. However, thisanalysis was only conducted from the e-
prescriptions and the pharmacy point of view. The patient's clinical conditionsare also the 
crucial determinantsin writing prescriptions. Thus, further studies are required to confirm these 
findings. 
Potential interactionsbetween 2 or more drugs with different severity in thee-prescriptions are 
shown in Table 5. From the analysis of potential drug interactions, there were 144 antagonistic 
pharmacodynamic interactions with the most frequently occurred were between amlodipine and 
metformin with moderate severity (quite clinically significant).  
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Table 5. Potential interactions between 2 or more drugs in thee-prescriptions [12-14] 
Mechanism of Interaction / Severity Category of Medication Errors  
C D 
Pharmacodynamic Antagonist 
   Minor 
   Moderate 
   Major 
 
1 
0 
0 
 
 
1 
135 
7 
 
Total 1 (0.1) 143 (10.3) 
Pharmacokinetics 
   Minor 
   Moderate 
   Major 
 
3 
0 
0 
 
 
0 
7 
32 
 
Total 3(0.2) 39 (2.8) 
Synergistic 
   Minor 
   Moderate 
   Major 
 
0 
0 
0 
 
0 
62 
2 
Total 0 64 (4.6) 
Total 4 (0.3) 246 (17.8) 
 
Potential medication errors were grouped based on the NCC MERP category, namely the NCC 
algorithm for the Index for Categorizing Medication Errors.The most frequently occurred 
pharmacodynamic interactions were between amlodipine and metformin categorized into 
moderate severity (quite clinically significant). Amlodipine, a calcium channel blocker, can 
reduce the effects of metformin (biguanide group) with unknown mechanism. Based on NCC 
MERP Index for Categorizing Medication Errors, as many as 4 events were identified as 
potential errors included into category C (errors that occur and reach the patient but does not 
endanger the patient).There were 246 events included into category D (errors that reach the 
patient and monitoring is needed to confirm that it does not cause harm to the patient and / or 
intervention needed to prevent harm
 
[13]. The drugs included into category D were combination 
of amlodipine and simvastatin with a pharmacokinetic interaction mechanism. Both amlodipine 
and simvastatin are metabolized by CYP3A4 and the interactions could occur as a result of 
competition when metabolized[14]. Theseare classified as major severity; thus, this combination 
should be avoided[15]. Other efforts to avoid the interaction is to reduce the dose of simvastatin 
to minimize the risk of side effects or replace simvastatin with other statin drugs that are not 
metabolized by CYP3A4.  
According to the analysis of error/unclear prescribing using the NCC algorithm, the Index for 
Categorizing Medication Errors, the incident belongs to category B in which errors occurred but 
the error did not reach the patient. The prescribers had corrected the amount of drug items 
before the prescription was given to the patients, so the errorswere avoided. 
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4. Conclusions 
The e-prescription flow in the health care has a path that can facilitate pharmacy service when 
an error occurs in the system, in which the physician will write the prescription manually so that 
the patient can still be served. Therefore, the medication errors were identified using prescribing 
indicator. 
The most frequently occurred prescriptions incompleteness was administration requirements in 
which 100% of the prescriptions had no physician‟s practice license and practice phone 
numbers, patient contact number aswell as gender and body weight of the patients. 
The the present study indicated that errors still occurred eventhough with the use of electronic 
prescribing system. Efforts should always be done to avoid and minimize these potential 
medication errors,especially category D which requires further monitoring or intervention since 
this event can result in many negative impacts on the patients‟ health. 
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